Rowena C. Punzalan, MD

Publications

• Efficacy of surveillance ultrasound for venous thromboembolism diagnosis in critically ill children after trauma.

  (Landisch RM, Hanson SJ, Punzalan RC, Braun K, Cassidy LD, Gourlay DM.) J Pediatr Surg. 2018 Nov;53(11):2195-2201 PMID: 29997028 SCOPUS ID: 2-s2.0-85049479648 07/13/2018

• Central Venous Catheter-associated Venous Thromboembolism in Children With Hematologic Malignancy.

  (Onyeama SN, Hanson SJ, Dasgupta M, Baker K, Simpson PM, Punzalan RC.) J Pediatr Hematol Oncol. 2018 Nov;40(8):e519-e524 PMID: 29863581 SCOPUS ID: 2-s2.0-85048252637 06/05/2018

• Evaluation of guidelines for injured children at high risk for venous thromboembolism: A prospective observational study.

  (Landisch RM, Hanson SJ, Cassidy LD, Braun K, Punzalan RC, Gourlay DM.) J Trauma Acute Care Surg. 2017 May;82(5):836-844 PMID: 28430759 SCOPUS ID: 2-s2.0-85014172433 04/22/2017

• Evaluation of guidelines for injured children at high risk for VTE: A prospective observational study.

  (Landisch RM, Hanson SJ, Cassidy LD, Braun K, Punzalan RC, Gourlay DM.) J Trauma Acute Care Surg. 2017 Mar 02 PMID: 28257391 03/04/2017

• Screening Guidelines for Venous Thromboembolism Risk in Hospitalized Children Have Low Sensitivity for Central Venous Catheter-Associated Thrombosis.

  (Asfaw AB, Punzalan RC, Yan K, Hoffmann RG, Hanson SJ.) Hosp Pediatr. 2017 Jan;7(1):39-45 PMID: 27965360 SCOPUS ID: 2-s2.0-85050580478 12/15/2016

• Use and Future Investigations of Recombinant and Plasma-Derived Coagulation and Anticoagulant Products in the Neonate.

  (Punzalan RC, Gottschall JL.) Transfus Med Rev. 2016 Oct;30(4):189-96 PMID: 27576087 SCOPUS ID: 2-s2.0-84994876768 09/01/2016

• A Pilot Study of Antithrombin Replacement Prior to Cardiopulmonary Bypass in Neonates.

  (Niebler RA, Woods KJ, Murkowski K, Ghanayem NS, Hoffman G, Mitchell ME, Punzalan RC, Scott JP, Simpson P, Tweddell JS.) Artif Organs. 2016 Jan;40(1):80-5 PMID: 26620919 SCOPUS ID: 2-s2.0-84956825530 12/02/2015

• Higher doses of low-molecular-weight heparin (enoxaparin) are needed to achieve target anti-Xa concentrations in critically ill children*.

  (Schloemer NJ, Abu-Sultaneh S, Hanson SJ, Yan K, Hoffmann RG, Punzalan RC, Havens PL.) Pediatr Crit Care Med. 2014 Sep;15(7):e294-9 PMID: 24901803 SCOPUS ID: 2-s2.0-84926087005 06/06/2014

• The use of novel Therakos™ Cellex® for extracorporeal photopheresis in treatment of graft-versus-host disease in paediatric patients.

  (Rangarajan HG, Punzalan RC, Camitta BM, Talano JA.) Br J Haematol. 2013 Nov;163(3):357-64 PMID: 23961954 SCOPUS ID: 2-s2.0-84885418957 08/22/2013

• Severe thrombocytopenia in a child secondary to passive platelet antibody transfer from a plasma transfusion.

  (Collins CL, Scott JP, Panepinto JA, Punzalan RC.) J Pediatr Hematol Oncol. 2013 Jul;35(5):e226-8 PMID: 23459377 PMCID: PMC4508016 03/06/2013

• Use of purified fibrinogen concentrate for dysfibrinogenemia and importance of laboratory fibrinogen activity measurement.

  (Franzblau EB, Punzalan RC, Friedman KD, Roy A, Bilen O, Flood VH.) Pediatr Blood Cancer. 2013 Mar;60(3):500-2 PMID: 23129109 PMCID: PMC4461026 SCOPUS ID: 2-s2.0-84872441623 11/07/2012

• Effectiveness of clinical guidelines for deep vein thrombosis prophylaxis in reducing the incidence of venous thromboembolism in critically ill children after trauma.

  (Hanson SJ, Punzalan RC, Arca MJ, Simpson P, Christensen MA, Hanson SK, Yan K, Braun K, Havens PL.) J Trauma Acute Care Surg. 2012 May;72(5):1292-7 PMID: 22673257 SCOPUS ID: 2-s2.0-84864550787 06/08/2012